Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Kurth

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Psychopharmacology Bulletin|October 26, 2002
Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's diseaseT E Gillen, K M Gregg, H Yuan, et al.
Cytogenetics and Cell Genetics|January 1, 1993
Linkage analysis of the monoamine A and B genes using newly-defined polymorphismsB D Harris, J H Kurth, R I Barnes, et al.
Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.
Clinical Neuropharmacology|May 10, 2000
Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonismK M Jorga, T L Davis, M C Kurth, et al.
Neuroepidemiology|May 21, 1998
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementiaJ P Hubble, J H Kurth, S L Glatt, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot studyW J Tremaine, A Brzezinski, J A Katz, et al.
Parkinsonism & Related Disorders|October 1, 1996
Prevalence of tremor and Parkinson's diseaseA S Khatter, M C Kurth, M A Brewer, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Psychopharmacology Bulletin|October 26, 2002
Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's diseaseT E Gillen, K M Gregg, H Yuan, et al.
Cytogenetics and Cell Genetics|January 1, 1993
Linkage analysis of the monoamine A and B genes using newly-defined polymorphismsB D Harris, J H Kurth, R I Barnes, et al.
Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.
Clinical Neuropharmacology|May 10, 2000
Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonismK M Jorga, T L Davis, M C Kurth, et al.
Neuroepidemiology|May 21, 1998
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementiaJ P Hubble, J H Kurth, S L Glatt, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot studyW J Tremaine, A Brzezinski, J A Katz, et al.
Parkinsonism & Related Disorders|October 1, 1996
Prevalence of tremor and Parkinson's diseaseA S Khatter, M C Kurth, M A Brewer, et al.
Pageof 2